» Articles » PMID: 20031849

The JUPITER Trial: Results, Controversies, and Implications for Prevention

Overview
Date 2009 Dec 25
PMID 20031849
Citations 57
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review.

Hirsch D, Lau B, Kushwaha V, Yong K Rev Cardiovasc Med. 2024; 24(6):181.

PMID: 39077541 PMC: 11264163. DOI: 10.31083/j.rcm2406181.


Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis.

Qin T, Ma T, Huang K, Lu S, Zhong J, Li J Curr Atheroscler Rep. 2024; 26(8):383-394.

PMID: 38878139 PMC: 11236888. DOI: 10.1007/s11883-024-01215-5.


Molecular and cellular mechanisms of inflammation in atherosclerosis.

Popa-Fotea N, Ferdoschi C, Micheu M Front Cardiovasc Med. 2023; 10:1200341.

PMID: 37600028 PMC: 10434786. DOI: 10.3389/fcvm.2023.1200341.


Statins for ACTA2 mutation-driven atherosclerosis?.

Zhang H, Halmos B, Westerterp M Eur Heart J. 2023; 44(29):2727-2729.

PMID: 37377008 PMC: 10393068. DOI: 10.1093/eurheartj/ehad364.


Lipoprotein(a): Role in atherosclerosis and new treatment options.

Tomic Naglic D, Manojlovic M, Pejakovic S, Stepanovic K, Simeunovic J Biomol Biomed. 2023; 23(4):575-583.

PMID: 37183706 PMC: 10351089. DOI: 10.17305/bb.2023.8992.